Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis

Published:2018-02-14 Issue:3 Volume:21 Page:535-546
ISSN:1875-8592
Container-title:Cancer Biomarkers
language:
Short-container-title:CBM

Author:

Xiong Jie¹,Xiong Ke²,Bing Zhitong³

Affiliation:

1. Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha, Hunan, China

2. School of Medicine, Tongji University, Shanghai, China

3. Department of Computational Physics, Institute of Modern Physics of Chinese Academy of Sciences, Lanzhou, Gansu, China

Publisher

IOS Press

Subject

Cancer Research,Genetics,Oncology,General Medicine

Reference46 articles.

1. Prognostic factors in superficial bladder A study of the european organization for research on treatment of cancer: Genitourinary tract cancer cooperative group;Dalesio;Journal of Urology,1983

2. Superficial bladder tumors (stage pTa, grades 1 and 2): The importance of recurrence pattern following initial resection;Fitzpatrick;Journal of Urology,1986

3. Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: Report from the british medical research council subgroup on superficial bladder cancer (urological cancer working party);Parmar;Journal of Urology,1989

4. The relationship among multiple recurrences, progression and prognosis of patients with stages TA and T1 transitional cell cancer of the bladder followed for at least 20 years – editorial comment;Soloway;Journal of Urology,1995

5. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: A combined analysis of 2596 patients from seven EORTC trials;Sylvester;European Urology,2006

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of miRNAs to Detect Progression, Stratify, and Predict Relevant Clinical Outcomes in Bladder Cancer;International Journal of Molecular Sciences;2024-02-11

2. MicroRNA-432 Acts as a Prognostic Biomarker and an Inhibitor of Cell Proliferation, Migration, and Invasion in Breast Cancer;Clinical Breast Cancer;2021-08

3. Development and validation of a molecular prognostic index of bladder cancer based on immunogenomic landscape analysis;Cancer Cell International;2020-07-11

4. Identification of prognostic gene biomarkers for metastatic skin cancer using data mining;Biomedical Reports;2020-05-18

5. Development of a novel six‐long noncoding RNA signature predicting survival of patients with bladder urothelial carcinoma;Journal of Cellular Biochemistry;2019-07-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3